News + Filings Transactions
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
|
|
Kiernan Jane E
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 06/28/2023 |
4
| Kiernan Jane E (Director) has filed a Form 4 on Axonics, Inc.|
Txns:
| Granted 3,000 shares
@ $0 |
|
| 05/25/2023 |
4
| Kiernan Jane E (Director) has filed a Form 4 on TREACE MEDICAL CONCEPTS, INC.|
Txns:
| Granted 2,753 shares
@ $0
Granted 6,305 options to buy
@ $26.34, valued at
$166.1k
|
|
| 10/04/2022 |
4
| Kiernan Jane E (Director) has filed a Form 4 on TREACE MEDICAL CONCEPTS, INC.|
Txns:
| Granted 2,832 shares
@ $0
Granted 19,439 options to buy
@ $22.07, valued at
$429k
|
|
| 08/22/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 07/07/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 03/31/2022 |
4
| Kiernan Jane E (Director) has filed a Form 4 on Axonics, Inc.|
Txns:
| Sold 3,500 shares
@ $60, valued at
$210k
Sold 1,750 shares
@ $61.4897, valued at
$107.6k
|
|
| 11/02/2021 |
4
| Kiernan Jane E (Director) has filed a Form 4 on Axonics, Inc.|
Txns:
| Granted 2,261 shares
@ $0 |
|
| 08/26/2020 |
4
| Kiernan Jane E (Director) has filed a Form 4 on Axonics Modulation Technologies, Inc.|
Txns:
| Granted 3,500 shares
@ $0 |
|
| 03/18/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 08/26/2019 |
4
| Kiernan Jane E (Director) has filed a Form 4 on Axonics Modulation Technologies, Inc.|
Txns:
| Granted 2,083 shares
@ $0
Granted 4,167 options to buy
@ $34.1, valued at
$142.1k
|
|
| 04/09/2019 |
4
| Kiernan Jane E (Director) has filed a Form 4 on Axonics Modulation Technologies, Inc.|
Txns:
| Granted 5,000 shares
@ $0
Granted 10,000 options to buy
@ $21.04, valued at
$210.4k
|
|
| 06/21/2011 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 05/03/2010 |
4
| Kiernan Jane E (Director) has filed a Form 4 on AMERICAN MEDICAL SYSTEMS HOLDINGS INC|
Txns:
| Granted 2,120 shares
@ $0
Granted 17,000 options to buy
@ $18.36, valued at
$312.1k
|
|
|
|